Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShort-Term Debt issuances
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 16 years, with Q2 2025 value amounting to $145.1 million.

  • Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments fell 79.54% to $145.1 million in Q2 2025 from the same period last year, while for May 2025 it was $145.8 million, marking a year-over-year decrease of 64.48%. This contributed to the annual value of $145.8 million for FY2025, which is 64.48% down from last year.
  • Per Lifecore Biomedical, Inc. \De\'s latest filing, its Long-Term Debt Repayments stood at $145.1 million for Q2 2025, which was down 79.54% from $313000.0 recorded in Q1 2025.
  • Lifecore Biomedical, Inc. \De\'s 5-year Long-Term Debt Repayments high stood at $146.2 million for Q2 2024, and its period low was -$29.5 million during Q4 2024.
  • Over the past 5 years, Lifecore Biomedical, Inc. \De\'s median Long-Term Debt Repayments value was $313000.0 (recorded in 2025), while the average stood at $35.1 million.
  • As far as peak fluctuations go, Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments skyrocketed by 34416000.0% in 2023, and later tumbled by 1539740.93% in 2024.
  • Quarter analysis of 5 years shows Lifecore Biomedical, Inc. \De\'s Long-Term Debt Repayments stood at $38000.0 in 2021, then rose by 28.95% to $49000.0 in 2022, then soared by 293.88% to $193000.0 in 2023, then plummeted by 15397.41% to -$29.5 million in 2024, then soared by 591.33% to $145.1 million in 2025.
  • Its last three reported values are $145.1 million in Q2 2025, $313000.0 for Q1 2025, and -$29.5 million during Q4 2024.